The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression

Authors
Publication date
31 October 2014
Publisher

Abstract

Pathophysiology and treatment of rheumatic disease

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Leiden University Scholary Publications

    redirect
    oaioai:scholarlypublications.univ...
    Last time updated on 12/03/2021